Rosemary Sinclair Dokos
Chief Commercial and Product Officer · NucleicAI
Rosemary Sinclair Dokos is a commercial and technology leader with extensive experience scaling biotechnology businesses and bringing pioneering scientific innovations to global markets.
She is Chief Commercial and Product Officer at NucleicAI, a next-generation biotechnology and data intelligence company operating at the intersection of artificial intelligence, genomics and longevity medicine. Working alongside a leadership team that includes Harvard professors and co-founders Alireza Haghighi and David A. Sinclair, Rosemary contributes to the company's commercial and product strategy as it advances AI-driven biological research, precision medicine and technologies supporting human longevity.
Rosemary previously held senior leadership responsibilities at Oxford Nanopore Technologies, where she played an important role in scaling the company's pioneering DNA and RNA sequencing technologies. Joining in 2014, she oversaw product management and commercial releases across sequencing devices, chemistry and software, helping translate scientific breakthroughs into globally accessible technologies.
Earlier in her career, she led the Market Development and Life Science division at VWR UK, overseeing technical sales, marketing and commercial operations across the scientific sector. She holds a BSc in Marine Sciences from the University of Southampton.